Все публикации

1:34:36

#XIVForoCIBERNED: I Sesión Científica.

0:06:08

CIBERNED - ¿Qué investigamos y por qué?

0:25:44

José Luis Labandeira: Brain Renin-angiotensin system and dopaminergic degeneration

0:26:57

Ana María Pérez: Phosphodiesterase-7 as a therapeutic target in Parkinson’s disease

0:19:05

Valentín Ceña: Nanomedicine:The future for therapeutics of neurodegenerative diseases?

1:28:46

IV CIIIEN 2016 - Poster Highlights

0:38:56

Round table: Transfer of knowledge and industry-academia interaction in neurodegenerative diseases

0:12:09

Javier Burgos (NeuronBio): AlzTEST®, a novel tool in blood for the diagnosis of Alzheimer’s disease

0:16:21

Carlos Buesa (Oryzon Genomics): LSD1 an epigenetic therapeutic target to modulate...

0:11:54

Ainhoa Alzualde (Biobide): Zebrafish as a tool for Drug Discovery and Target Validation...

0:10:51

Raúl Insa (SOM Biotech): Repurposing drugs in Neurodegenerative Disorders

0:16:46

Antonio Gómez (Janssen): New Models to Fulfill the Potential of Basic Research

0:14:24

David Pardoe: Collaborative Drug Discovery Opportunities for Neurodegenerative Diseases

0:22:31

Juan Carlos López: Challenges and opportunities in transfer of knowledge from academy to industry

0:47:51

Luc Buée: Tau experimental models and therapeutic strategies

0:23:15

Beca de la Fundación Reina Sofía-MAPFRE - Olatz Arteaga

0:23:14

Eduardo Tolosa: Biomarkers of prodromal Parkinson disease

0:18:11

María M Puigdellívol: A role for Kalirin-7 in corticostriatal synaptic dysfunction...

0:22:36

Alberto Lleó: Synaptic abnormalities in Alzheimer’s disease and other dementias

0:22:16

Eva Carro: Metabolic Disorders and inflammation as risk factors for alzheimer’s disease

0:53:46

Eckhard Mandelkow: Role of Tau protein in Alzheimer Disease and neurodegenerative tauopathies

0:20:17

IV ciiien 2016 - Official Opening

0:44:44

Anthony Schapira: The Glucocerebrosidase pathway: a paradigm for pathogenesis and treatment...

0:45:48

Bengt Winblad: Alzheimer´s Disease - Present and future Treatment Strategies